News

Ideas That Generate Results

Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19 Million by 2025. The global cancer generics market is expected to witness a steep growth owing to the patent expiry of blockbuster cancer drugs. The ability of cancer generics to reduce healthcare costs is another driving factor for this industry.
 
Research Analysis and Highlights
 
According to our report, “Global Cancer Generics Market Forecast to 2022”, in the wake of the above mentioned developments the Global Cancer Generics Market is expected to grow at a CAGR of around 16% from 2016–2022. The market segmentations by mode of administration, by geography and by major indications have been mentioned in the report. The global cancer generics market has been segmented on the basis of mode of administration into oral and injectables. The report also highlights the major cancer generic drugs available in the global market.
 
Furthermore, the global cancer generics market has also been segmented on the basis of the major indications they are used for. Based on geography, the report divides the market into US, Europe, and Asia-Pacific. Moreover, the report also lists down various mergers and acquisitions taking place in the global generics industry.
 
The report also covers the key players of the Global Cancer Generics Market. For every player, a brief business overview and key financials has been provided. The product portfolio and recent developments of each player have also been listed down.
 
Some of the key findings of the report are:
 

 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM862.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm